transcripts

TRANSCRIPT: Meeting 5, Concluding Remarks

DR. GUTMANN:  I just want to join all of the commission members and our vice chair, Jim Wagner in saying that this has been very helpful to us.  And also thank you all for coming so far to give us your advice.  We will be back in touch with you to get various writings and other suggestions from you.  But in the meantime, now that my red light is on, I want to ask everybody, and I also want to thank the public members of our audience for really getting us off to a great start on this very important topic.  So thank you all very, very much.

Date

Thu, 05/19/2011

TRANSCRIPT: Meeting 5, Session 9

DR. GUTMANN:  Many thanks to everyone.  And I would like everybody who has presented today to give us some of their advice and then we’ll open it up to questions.  

Date

Thu, 05/19/2011

TRANSCRIPT: Meeting 5, Session 8

DR. WAGNER: We’ve got forty-five minutes to talk about the European perspective – we’re going to take our whole forty-five minutes because we expect to be just as rich as the prior conversation was.

Date

Thu, 05/19/2011

TRANSCRIPT: Meeting 5, Session 7

DR. GUTMANN:  Thank you all very much. As you know, the subject of our present investigation is human subjects research, and specifically, the protection of human subjects, both national and international, with the particular focus on the international dimension. And this panel is brought together to discuss transnational standards of human subjects research and we’re going to begin with John Williams.

Date

Thu, 05/19/2011

TRANSCRIPT: Meeting 5, Session 6

DR. WAGNER:  Where is Steve and Barbara? In order that we maximize the time that we have available, I think we ought to get going. This is the public comments session. You know, a couple of process issues, first of all, to remind folks that the Commission staff published an inventation prior to this meeting in the Federal Register inviting comment. I understand there was something on the order of 300 people who wish to offer comment.

Date

Wed, 05/18/2011

TRANSCRIPT: Meeting 5, Session 5

 DR. GUTMANN:  We are going to make a seamless segue into a panel discussion so I'd ask everybody who has presented to come on up and I think we'll add perhaps a few seats to the table.
  First of all, thank you all for joining us, and it’s a great privilege for us to have you here to share your wisdom with us on a set of very thorny and important issues. So, we’ve made a practice of this, and you’ve got to trust us, it works, even though it’s going to impose a discipline on you.

Date

Wed, 05/18/2011

TRANSCRIPT: Meeting 5, Session 4

DR. WAGNER: For session 4, our Chair.

Date

Wed, 05/18/2011

TRANSCRIPT: Meeting 5, Session 3

DR. WAGNER: Well, good afternoon. Welcome everyone to the session 3 of our meeting, Implementing Federal Standards and International Standards.  We have for our first panel Dr. Murray Lumpkin, Mack Lumpkin, and also Dr. Jerry Menikoff.  Let me introduce Dr.

Date

Wed, 05/18/2011

TRANSCRIPT: Meeting 5, Opening Remarks

P-R-O-C-E-E-D-I-N-G-S

                                     9:00 a.m.

            DR. GUTMANN:  If I could ask all the Commission members, please, to take their seats. Good morning,  I'm Amy Gutmann and I'm President of the University of Pennsylvania and Chair of the Presidential Commission for the Study of Bioethical Issues. 

Date

Thu, 05/19/2011

Pages

Subscribe to RSS - transcripts